STOCK TITAN

HealWELL AI Inc. Stock Price, News & Analysis

HWAIF OTC

Welcome to our dedicated page for HealWELL AI news (Ticker: HWAIF), a resource for investors and traders seeking the latest updates and insights on HealWELL AI stock.

HEALWELL AI Inc. (OTCQX: HWAIF; TSX: AIDX) regularly issues news updates as a healthcare artificial intelligence company focused on preventative care and early disease detection. Its announcements describe how the company is developing and commercializing proprietary clinical decision support systems and AI platforms intended to help healthcare providers detect rare and chronic diseases, improve efficiency, and support better patient outcomes.

News releases from HEALWELL cover a range of topics, including financial and operational updates, strategic acquisitions and divestments, and progress in integrating acquired businesses such as Orion Health. The company has reported a transition toward a pure-play digital SaaS, services and AI business focused on health systems and large enterprise customers, and its news flow reflects this emphasis on enterprise-grade healthcare software and data science offerings.

HEALWELL’s news also highlights developments in its AI platforms, including the DARWEN™ AI system and the launch of AmadeusAI, an AI-enabled digital care record built on Orion Health’s Amadeus platform. Announcements have described new AI tools such as SMARTSearch, SMARTSummary, and SMARTIdentify, as well as collaborations with public health organizations, healthcare systems, and life sciences partners.

Investors and observers can use this news page to follow HEALWELL’s disclosures on corporate transactions, joint ventures, memoranda of understanding, recognition of its AI technologies in peer-reviewed studies, and participation in industry and investment conferences. The updates provide context on how the company presents its strategy in preventative healthcare AI, its focus on real-world data and evidence generation, and its orientation toward large-scale health system and enterprise deployments.

Rhea-AI Summary

HEALWELL (OTCQX: HWAIF) reported that its DARWEN™ AI platform generated regulatory-grade real-world data (RWD) supporting vedolizumab dose escalation from every 8 weeks to every 4 weeks, with improved remission outcomes for ulcerative colitis and Crohn's disease.

HEALWELL presented these AI-generated RWD findings with Takeda on October 6, 2025 at UEG Week in Berlin. The company says DARWEN has 40+ peer-reviewed publications and was named a finalist in Newsweek's AI Impact Awards 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.05%
Tags
AI
-
Rhea-AI Summary

HEALWELL AI (OTCQX: HWAIF) has announced the global launch of AmadeusAI, a significant milestone in integrating DARWEN™ AI technology with Orion Health's Amadeus platform. The enhanced platform introduces the SMARTSuite of AI tools, including SMARTSearch, SMARTSummary, and SMARTIdentify.

AmadeusAI builds upon Orion Health's established Amadeus Digital Care Record, which has served over 150 million patients across 15 countries. The platform consolidates health and social care data into a comprehensive patient view, enabling healthcare providers to analyze clinical data, identify at-risk patients, and make informed decisions at the point of care.

The upgrade is now available to existing Amadeus customers, representing a key proof point of the Orion Health acquisition's success. The platform has been previously deployed across major healthcare systems including NHS Integrated Care Systems, U.S. Health Information Exchanges, and various national health networks.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.48%
Tags
AI
-
Rhea-AI Summary

HEALWELL AI (OTCQX: HWAIF), a healthcare artificial intelligence company specializing in preventative care, will present at the 2025 Cantech Investment Conference on October 9, 2025, in Toronto. The company's presentation is scheduled for 2:00 PM EST at the Arcadian Loft.

Dr. Alexander Dobranowski, President, and Anthony Lam, CFO, will deliver an investor presentation and conduct one-on-one meetings with investors. Additionally, Dr. Dobranowski will participate in the Lunch Keynote Panel titled "AI Investment Opportunities", where he will discuss HEALWELL's capital allocation strategy and recent growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences AI
Rhea-AI Summary

HEALWELL AI (OTCQX: HWAIF) announced that its subsidiary Intrahealth Systems has been selected by Public Health Sudbury & Districts to implement Profile, an enterprise-grade electronic medical record platform. The implementation aims to enhance public health infrastructure across Sudbury and Manitoulin districts.

Profile will support various public health programs including infectious disease control, vaccination management, sexual health services, health promotion, oral health programs, and environmental health. The platform features advanced capabilities such as predictive analytics, integrated telemedicine, real-time reporting, and client self-service features.

The system ensures compliance with privacy frameworks including PHIPA, HIPAA, and PIPEDA, while offering robust disaster recovery and mobile functionality. Profile is already deployed across many Ontario public health units and will help improve administrative efficiency, enhance data quality, and increase accessibility through digital portals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
none
-
Rhea-AI Summary

HEALWELL AI (OTCQX: HWAIF) reported exceptional Q2-2025 results, with revenue surging 645% to $40.5 million compared to $5.4 million in Q2-2024. The company achieved its first positive Adjusted EBITDA of $1.9 million, marking a significant turnaround from a $3.7 million loss in Q2-2024.

The growth was primarily driven by the Orion Health acquisition, which contributed to a 1,064% year-over-year increase in Healthcare Software business. The company maintained a strong financial position with $19 million in cash as of June 30, 2025. HEALWELL's Board is seeking strategic alternatives for clinical research and patient services units to transform into a pure-play digital SaaS and AI company.

Notable achievements include a gross margin of 52.5%, strategic expansion into the U.S. market, and full acquisition of Pentavere. The AI segment showed strong momentum with $5.1 million in revenue for H1 2025, representing 223% year-over-year growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.34%
Tags
-
Rhea-AI Summary

HEALWELL AI (OTCQX:HWAIF), a healthcare artificial intelligence company specializing in preventative care, will release its Fiscal Second Quarter 2025 financial results on August 13, 2025.

The company will host a conference call and simultaneous webcast at 1:00 PM ET on the same day. The call will feature CEO James Lee, President Dr. Alexander Dobranowski, and CFO Anthony Lam discussing the quarterly results.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.42%
Tags
Rhea-AI Summary

HEALWELL AI (OTCQX: HWAIF) reported significant growth in its AI business segment, with preliminary revenues expected to exceed $5 million for H1 2025, representing a 200% year-over-year increase. The company has exercised its call option to acquire the remaining 49% stake in Pentavere Research Group for approximately $14 million, paid through the issuance of 10.16 million Subordinate Voting Shares.

Under new CEO James Lee's leadership, HEALWELL's AI division, including Pentavere, Khure Health, and Mutuo Health Solutions, is expected to achieve positive Adjusted EBITDA in H1 2025. Both Pentavere and Khure have shown over 100% organic revenue growth in the first half of 2025. The company plans to integrate its AI and data science products deeper into its software platforms, leveraging Pentavere's DARWEN™ platform for preventative care solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.24%
Tags
-
Rhea-AI Summary

HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF), a healthcare AI company specializing in preventative care, has announced the voting results from its Annual General Meeting held on June 30, 2025. The meeting saw a 71% shareholder participation rate either in person or by proxy.

All proposed matters were successfully passed, including fixing the board size at six directors and the appointment of Deloitte LLP as the company's new external auditor, replacing PricewaterhouseCoopers LLP. The auditor appointment received 99.98% approval from shareholders.

All six incumbent directors were re-elected with overwhelming support, each receiving over 99% approval. The directors include Alexander Dobranowski, Hamed Shahbazi, Erik Danudjaja, Ian McCrae, Sam Englebardt, and Tina Raja.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.59%
Tags
AI
-
Rhea-AI Summary
HEALWELL AI Inc. (HWAIF) announces strategic expansion into the U.S. healthcare market, leveraging Orion Health's established presence across eight states. The company will integrate its AI-enabled tools with Orion's health data infrastructure software, targeting the U.S. digital health market valued at $160.4B in 2024 and projected to reach $695.2B by 2033 (15.4% CAGR). HEALWELL's offering includes FHIR-native repository and AI tools for clinical search, summarization, and risk stratification. The company serves major pharmaceutical companies and healthcare organizations through subsidiaries Pentavere and Khure Health. This expansion capitalizes on Orion's two-decade experience in U.S. healthcare, serving HIEs, ACOs, and health systems, while positioning HEALWELL to pursue additional strategic partnerships and M&A opportunities in the growing preventative care AI market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.02%
Tags
AI
Rhea-AI Summary
WELL Health Technologies (WHTCF) announces that three of its subsidiaries - Intrahealth, Pentavere, and OceanMD - have been selected for Canada Health Infoway's 2025 Vendor Innovation Program. These subsidiaries, representing three out of eight total winners, will develop projects focused on improving healthcare interoperability across Canada. Pentavere will integrate its DARWEN™ AI system with EMRs, OceanMD will enhance its eReferral system with AI automation, and Intrahealth will develop FHIR-based tools for patient record transfers. The projects will be implemented across multiple provinces including Alberta, British Columbia, Ontario, New Brunswick, and Nova Scotia, aiming to improve data quality, enhance care coordination, and expand access to standardized health information.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.43%
Tags
AI

FAQ

What is the current stock price of HealWELL AI (HWAIF)?

The current stock price of HealWELL AI (HWAIF) is $0.469 as of February 24, 2026.

What is the market cap of HealWELL AI (HWAIF)?

The market cap of HealWELL AI (HWAIF) is approximately 284.6M.

HWAIF Rankings

HWAIF Stock Data

284.59M
17.48M
Medical Care Facilities
Healthcare
Link
Canada
Toronto

HWAIF RSS Feed